NDC11 69097068412
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69097-0684-12 | 69097-0684 |
| 69097-684-12 | 69097-684 |
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 69097-684 | 69097-684-12 | D | Discontinued by firm | 2026-08-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PREGABALIN capsules, CV | PREGABALIN CAPSULES, CV | Cipla USA Inc. | 7d93359c-1849-430d-a922-21d42932d0f3 | 2025-12-22 | Warnings, Adverse reactions | 69097-684-12 69097-684 69097068412 |